Skip to content

Avoidance of Hyperglycaemia in People With Type 1 Diabetes

Avoidance of Hyperglycaemia in People With Type 1 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04732780
Acronym
HYPE
Enrollment
253
Registered
2021-02-01
Start date
2021-03-02
Completion date
2022-04-20
Last updated
2023-08-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 1

Keywords

Diabetes, Hyperglycaemia, Psychology

Brief summary

This study aims to learn more about avoidance of hyperglycaemia in adults with type 1 diabetes. People who attend a type 1 diabetes clinic will be invited to complete a number of self-report questionnaires and a survey. A subsection of people who experience avoidance of hyperglycaemia will be invited to take part in an interview in order to gain a more in-depth understanding of this issue.

Interventions

OTHERNo intervention

No intervention

Sponsors

Imperial College Healthcare NHS Trust
CollaboratorOTHER
Imperial Health Charity
CollaboratorOTHER
Imperial College London
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Type 1 diabetes of at least 6 months duration

Exclusion criteria

* Inability to understand or write in the English language * Pregnant women * Unable to participate in the study due to other factors, as assessed by the Chief Investigators

Design outcomes

Primary

MeasureTime frameDescription
Hyperglycaemia Avoidance ScaleBaselineQuestionnaire. Scored 0-96, with higher scores suggesting greater hyperglycaemia avoidance
General Anxiety Disorder-7 (GAD-7)BaselineQuestionnaire. Scored 0-21, with higher scores suggesting greater anxiety
Patient Health Questionnaire 9 (PHQ-9)BaselineQuestionnaire. Scored 0-27, with higher scores suggesting greater depression
State Trait Anxiety Inventory - Trait SubscaleBaselineQuestionnaire. Scored 20-80, with higher scores suggesting higher levels of trait anxiety
Hypoglycaemia Fear Survey 2 - Behaviour SubscaleBaselineQuestionnaire. Behaviour subscale scored 0-60; Worry subscale scored 0-72, in both cases with higher scores suggesting greater fear of hypoglycaemia. Please see outcome measure 7 for worry subscale results.
Problem Areas in Diabetes 5BaselineQuestionnaire. Scored 0-20, with higher scores suggesting greater diabetes stress.
Hypoglycaemia Fear Survey 2 - Worry SubscaleBaselineQuestionnaire. Behaviour subscale scored 0-60; Worry subscale scored 0-72, in both cases with higher scores suggesting greater fear of hypoglycaemia Please see outcome measure 5 for behaviour subscale results.

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Questionnaire Group
Individuals who attend the type 1 diabetes clinic will complete a number of self-report questionnaires and a survey. No intervention: No intervention
253
Total253

Baseline characteristics

CharacteristicQuestionnaire Group
Age, Continuous48.7 years
STANDARD_DEVIATION 15.8
Race and Ethnicity Not Collected— Participants
Region of Enrollment
United Kingdom
253 Participants
Sex: Female, Male
Female
150 Participants
Sex: Female, Male
Male
103 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 253
other
Total, other adverse events
0 / 253
serious
Total, serious adverse events
0 / 253

Outcome results

Primary

General Anxiety Disorder-7 (GAD-7)

Questionnaire. Scored 0-21, with higher scores suggesting greater anxiety

Time frame: Baseline

ArmMeasureValue (MEDIAN)
Questionnaire GroupGeneral Anxiety Disorder-7 (GAD-7)4 score on a scale
Primary

Hyperglycaemia Avoidance Scale

Questionnaire. Scored 0-96, with higher scores suggesting greater hyperglycaemia avoidance

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Questionnaire GroupHyperglycaemia Avoidance Scale44.6 score on a scaleStandard Deviation 12.6
Primary

Hypoglycaemia Fear Survey 2 - Behaviour Subscale

Questionnaire. Behaviour subscale scored 0-60; Worry subscale scored 0-72, in both cases with higher scores suggesting greater fear of hypoglycaemia. Please see outcome measure 7 for worry subscale results.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Questionnaire GroupHypoglycaemia Fear Survey 2 - Behaviour Subscale17.2 score on a scaleStandard Deviation 8.2
Primary

Hypoglycaemia Fear Survey 2 - Worry Subscale

Questionnaire. Behaviour subscale scored 0-60; Worry subscale scored 0-72, in both cases with higher scores suggesting greater fear of hypoglycaemia Please see outcome measure 5 for behaviour subscale results.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Questionnaire GroupHypoglycaemia Fear Survey 2 - Worry Subscale26.1 score on a scaleStandard Deviation 13.7
Primary

Patient Health Questionnaire 9 (PHQ-9)

Questionnaire. Scored 0-27, with higher scores suggesting greater depression

Time frame: Baseline

ArmMeasureValue (MEDIAN)
Questionnaire GroupPatient Health Questionnaire 9 (PHQ-9)5 score on a scale
Primary

Problem Areas in Diabetes 5

Questionnaire. Scored 0-20, with higher scores suggesting greater diabetes stress.

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Questionnaire GroupProblem Areas in Diabetes 58 score on a scaleStandard Deviation 4.9
Primary

State Trait Anxiety Inventory - Trait Subscale

Questionnaire. Scored 20-80, with higher scores suggesting higher levels of trait anxiety

Time frame: Baseline

ArmMeasureValue (MEAN)Dispersion
Questionnaire GroupState Trait Anxiety Inventory - Trait Subscale42.4 score on a scaleStandard Deviation 12.5

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026